AZZ vs WSC

AZZ has a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score for distress risk assessment. Despite strong profitability metrics like a 27.38% ROE and solid earnings growth, recent insider selling and declining EPS trends raise caution. The stock trades below the analyst target price but at a significant premium to the conservative Graham Number of $101.88, while forward P/E expansion suggests growth expectations are already priced in. Mixed signals from strong historical returns and solid margins against weakening recent earnings momentum result in a neutral stance.

WSC exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. The company is burdened by excessive leverage (Debt/Equity of 4.56) and liquidity constraints (Current Ratio of 0.86), which are compounded by negative net profit margins and declining revenue growth (-6.10% YoY). Despite a recent short-term price spike and a 'Buy' consensus from analysts, the company has missed earnings estimates in 4 consecutive quarters with an average surprise of -17.02%. The disconnect between analyst optimism and the deterministic health scores suggests a high-risk profile.